Stage IV Salivary Gland Cancer Completed Phase 2 Trials for Capecitabine (DB01101)

Also known as: Salivary gland cancer stage IV / Metastatic salivary gland cancer / Malignant salivary gland cancer stage IV

IndicationStatusPhase
DBCOND0028780 (Stage IV Salivary Gland Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01044433Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and NeckTreatment